Home
>
National Drug Code (NDC)
>
Ethosuximide
Ethosuximide - 50111-901-01 - (Ethosuximide)
Drug Information of Ethosuximide
| Product NDC: | 50111-901 |
| Proprietary Name: | Ethosuximide |
| Non Proprietary Name: | Ethosuximide |
| Active Ingredient(s): | 250 mg/1 & nbsp; Ethosuximide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ethosuximide
| Product NDC: | 50111-901 |
| Labeler Name: | Pliva Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040430 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20021101 |
Package Information of Ethosuximide
| Package NDC: | 50111-901-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (50111-901-01) |
NDC Information of Ethosuximide
| NDC Code | 50111-901-01 |
| Proprietary Name | Ethosuximide |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (50111-901-01) |
| Product NDC | 50111-901 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ethosuximide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20021101 |
| Marketing Category Name | ANDA |
| Labeler Name | Pliva Inc. |
| Substance Name | ETHOSUXIMIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
